Takeda: Excellent Pipeline Kaizen - 6 Drugs, $20 Billion Annually
Takeda offers a compelling investment case with six late-stage therapies targeting $20 billion in peak sales by 2030-31. Click to read why TAK is a Strong Buy.
Read more
Silvia Venturini Fendi asserts creative control with a colorful, youthful Milan runway collection
MILAN (AP) — Silvia Venturini Fendi has taken full creative control of her family’s fashion house, unleashing her powers on a co-ed Spring-Summer 2026 collection previewed during Milan Fashion Week on... Read Full Article →
Outcrop Silver Announces $20 Million Public Offering
Not for distribution to U.S. news wire services or dissemination in the United States. VANCOUVER, British Columbia, Sept. 24, 2025 (GLOBE NEWSWIRE) — Outcrop Silver & Gold Corporation (TSXV:OCG, OTCQX:OCGSF, DE:MRG) (“Outcrop Silver” or the “Company”) is pleased to announce that it has entered into an agreement
Urgent ETH Price Prediction: Is a Drop to $4,000 Inevitable for Ethereum?
BitcoinWorldUrgent ETH Price Prediction: Is a Drop to $4,000 Inevitable for Ethereum?The cryptocurrency market is a dynamic landscape, and for Ethereum (ETH) holders, recent signals are raising alarms. A new ETH price prediction from a prominent analyst suggests that the second-largest cryptocurrency could be on the verge of
KINDERCARE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has ...
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In KinderCare (KLC) To Contact Him Directly To Discuss Their Options Read Full Article →
